αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer

Autor: de Groot, Jolien S., Ratze, Max A.K., van Amersfoort, Miranda, Eisemann, Tanja, Vlug, Eva J., Niklaas, Mijanou T., Chin, Suet Feung, Caldas, Carlos, van Diest, Paul J., Jonkers, Jos, de Rooij, Johan, Derksen, Patrick W.B.

Publikováno v: Journal of Pathology, 245(4), 456. John Wiley and Sons Ltd

Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast cancer (ILC), approximately 10-15% of all ILCs retain membrane-localized E-cadherin despite the presence of an apparent non-cohesive and invasive lobu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e217f38bbeb39b8533c94bc15a435cb
https://dspace.library.uu.nl/handle/1874/371349

αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer

Autor: de Groot, Jolien S, Ratze, Max AK, van Amersfoort, Miranda, Eisemann, Tanja, Vlug, Eva J, Niklaas, Mijanou T, Chin, Suet-Feung, Caldas, Carlos, van Diest, Paul J, Jonkers, Jos, de Rooij, Johan, Derksen, Patrick WB

Publikováno v: The Journal of Pathology. 245(4):456-467

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=sygma_______::c443805635526ea599976fd8a3a8b28a

αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.

Autor: de Groot JS; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Ratze MA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van Amersfoort M; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Eisemann T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Vlug EJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Niklaas MT; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Jonkers J; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Rooij J; Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands., Derksen PW; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: The Journal of pathology [J Pathol] 2018 Aug; Vol. 245 (4), pp. 456-467. Date of Electronic Publication: 2018 Jun 20.